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OBJECTIVES The aim of this study was to evaluate how decreased plaque volume during percutaneous
coronary intervention (PCI) affects coronary flow in patients with acute myocardial infarction
(AMI).
BACKGROUND Coronary flow after reperfusion therapy is a major determinant of clinical outcomes in
patients with AMI. However, little is still known about the changes in coronary flow that
appear after PCI in response to the decreased plaque during the procedure.
METHODS The study group comprised 60 patients with AMI who underwent pre- and post-PCI
intravascular ultrasound (IVUS). Qualitative and quantitative analyses were performed on all
IVUS procedures. External elastic membrane volume (EEMV), lumen volume (LV), and
plaque volume (PV) were measured every 1.0 mm to include the lesion and reference
segments 3.0 mm proximal and distal to the lesion. The difference between pre- and
post-PCI PV was defined as the index of the decrease in plaque volume (PV). The corrected
TIMI frame count (CTFC) was used to evaluate coronary flow after PCI.
RESULTS Plaque volume was decreased at post-PCI IVUS in all 60 patients. Inadequate reflow (CTFC
40) was observed in 13 patients (21.7%). The decrease in PV was significantly larger in
patients with inadequate reflow than in those with reflow (49.4  18.9 vs. 31.7  15.5 mm3,
p  0.0010). Also, PV was significantly correlated with CTFC after PCI (r  0.415, p 
0.0012).
CONCLUSIONS The decrease in PV during PCI has a negative impact on coronary flow after PCI in patients
with AMI. Embolization induced by PCI may occur in all patients with AMI. (J Am Coll




















cercutaneous coronary intervention (PCI) is widely per-
ormed in patients with acute myocardial infarction (AMI)
n order to restore the patency and adequate reflow in the
nfarct-related artery as early as possible. Unfortunately,
CI does not always guarantee a good clinical outcome. In
act, the procedure fails to achieve Thrombolysis In Myo-
ardial Infarction (TIMI) flow grade 3 in 2% to 30% of
ases, mainly due to the angiographic no-reflow phenome-
on (1,2). Coronary flow after reperfusion therapy is a major
eterminant of clinical outcomes in patients with AMI
3–11). The TIMI flow grade classification (3) has been a
aluable tool to compare angiographic and clinical outcomes
fter thrombolysis (4–9). Moreover, excellent epicardial
lood flow, as assessed by the corrected TIMI frame count
CTFC), is reported to be associated with improved in-
ospital and one-month clinical outcomes after thrombo-
ytic administration (10,11).
Recent studies have indicated that PCI-induced plaque
r thrombus release in patients with AMI might be attrib-
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eported that particulate debris after saphenous vein graft
ntervention might contribute to distal embolization, no-
eflow, and infarction. However, there have been few studies
o clarify the effect of distal embolization on coronary flow
fter PCI in patients with AMI. The aim of this study was
o investigate the effect of the decrease in plaque during PCI
n coronary flow in patients with AMI.
ETHODS
tudy population. Of 70 consecutive patients with first
MI who underwent intravascular ultrasound (IVUS)-
uided PCI in Tsukazaki Memorial Hospital between
ebruary 2000 and September 2002, a total of 60 who
nderwent pre- and post-PCI IVUS were enrolled in the
resent study. All patients were successfully recanalized with
tenting within 12 h of the onset of symptoms. The
iagnosis of AMI was determined from the presence of
ontinuous chest pain for more than 30 min, ST-segment
levation above 0.2 mV on at least two contiguous electro-
ardiographic (ECG) leads, a threefold increase in serum
reatine kinase (CK) levels, and TIMI flow grade 0, 1, or 2
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July 21, 2004:300–4 Plaque Volume Change and Coronary Flowitroglycerin was the only agent used before and during the
CI procedure (no patients underwent thrombolysis or
eceived glycoprotein IIb/IIIa inhibitors, adenosine, or ve-
apamil). No patients with a previous myocardial infarction,
ubacute thrombosis, or cardiogenic shock were enrolled in
he study.
Of the original 70 patients, 10 were excluded from the
tudy for the following reasons: 5 patients with ostial and
ifurcation lesions were excluded due to difficulty in ana-
yzing the media-adventitia border and the possibility that
he plaque would shift out of the range of the ultrasound
mage; 3 were excluded due to an inadequate IVUS image;
nd 2 were excluded due to the use of intra-aortic balloon
umping or percutaneous cardiopulmonary support during
CI.
The Ethics Committee of Tsukazaki Memorial Hospital
pproved the study protocol, and written, informed consent
as obtained from all participants before coronary angiog-
aphy.
tudy protocol. All patients were treated by primary PCI
ith stenting, and all received heparin (100 U/kg) before
he routine catheterization procedure. Immediately after
iagnosis, the patients underwent coronary angiography and
re-PCI IVUS. Percutaneous coronary intervention was
erformed using a 7F-guiding catheter, 0.014-inch guide-
ire, monorail balloon catheter, and stent, according to
onventional methods. Decision-making on the PCI strat-
gy was left to the discretion of an individual PCI
ardiologist.
Post-PCI IVUS and final angiography were performed
fter PCI, and the CTFC determined on angiography was
sed to assess post-PCI coronary flow. Inadequate reflow
as defined as CTFC 40 in the absence of mechanical
bstruction on the final angiograms after PCI. The IVUS
atheter (3.2F Ultra cross, CVIS, Boston Scientific, Natick,
assachusetts) was carefully advanced distal to the lesion
nder fluoroscopic guidance, then pulled back automatically
rom the distal portion at 0.5 mm/s. As the catheter was
ulled back, we manually infused a contrast medium for the
VUS image, carefully identifying the lumen area and lesion
orphology. The IVUS images were recorded on S-VHS
Abbreviations and Acronyms
AMI  acute myocardial infarction
CK-MB  creatine kinase-MB fraction
CTFC  corrected TIMI frame count
EEM-CSA  external elastic membrane cross-sectional
area
EEMV  external elastic membrane volume
IVUS  intravascular ultrasound
L-CSA  lumen cross-sectional area
LV  lumen volume
PCI  percutaneous coronary intervention
PV  plaque volume
TIMI  Thrombolysis In Myocardial Infarctionideotape for off-line analysis. wThe angiographic criterion of25% residual stenosis was
sed to determine the end point of PCI. Post-PCI IVUS
as performed to exclude the possibility of mechanical
essel obstruction, including thrombus or dissection.
nalysis of IVUS image. Two independent observers who
ad no knowledge of the diagnoses and angiographic results
erformed off-line analysis of the recorded images after the
rocedure. Cross sections were analyzed for every 2 s of
ideotape, and each analyzed coronary segment was axially
ivided into several 1.0-mm segments. Quantitative mea-
urements of the ultrasound images were performed at the
iastolic phase every 2 s. When we encountered the systolic
hase on the IVUS image, we shifted the image back and
orth to the nearest diastolic phase. Identification of the side
ranches by IVUS and the presence of a calcified lesion were
lso helpful to locate the position of the IVUS transducer.
n the basis of reproducible arterial landmarks, the same
rterial segments were identified at the pre- and post-PCI
ssessments. The analyzed arterial segments encompassed
he stented segments and reference segments 3.0 mm
roximal and distal to the stented segments.
The morphologic features were classified according to a
revious report (12). The methods for identifying the
laque composition and measuring the external elastic
embrane cross-sectional area (EEM-CSA) by IVUS were
lso reported previously (15–17). The EEM-CSA was
easured by tracing the outer border of the sonolucent
one, and an incidence of lesion EEM-CSA larger than
roximal reference EEM-CSA was defined as positive
emodeling. The lumen cross-sectional area (L-CSA) was
easured by tracing the interface between the vessel lumen
nd the leading edge of the initial echogenic layer. When
laque and thrombus encompassed the catheter, L-CSA
as assumed to be the size of the imaging catheter. The
laque area was calculated as EEM-CSA minus L-CSA.
ach image slice was tabulated separately and used to
alculate the external elastic membrane volume (EEMV),
umen volume (LV), and plaque volume (PV), according to
impson’s rule.
ngiographic analysis. Coronary angiograms were re-
iewed separately by two independent observers who were
naware of the IVUS findings. To objectively evaluate an
ndex of coronary flow as a continuous quantitative variable,
he CTFC was measured with a frame counter on the ELK
AP-35B II cineviewer (ELMO, Nagoya, Japan). All
ngiograms were filmed at 30 frames/s. The CTFC after
CI in the infract-related artery was counted. Collateral
ow was graded according to the Rentrop classification (18),
ith good collateral flow defined as grade 2 or 3.
tatistical analysis. All analyses were performed using
tatView version 5.0 (Abacus Concepts). The results are
xpressed as the mean value  SD for each measurement.
ontinuous variables were compared using both the paired
nd unpaired Student t test. Pearson’s correlation coefficient
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Plaque Volume Change and Coronary Flow July 21, 2004:300–4ous variables. Statistical significance in all comparisons was
 0.05.
ESULTS
ll 60 patients were treated by primary PCI with stenting,
nd eight of them had tandem stents without gaps. The
atient characteristics are summarized in Table 1. Coronary
rtery lesions were observed with IVUS in all 60 patients
ithout serious procedural complications. Blood flow distal
o the culprit lesion was detectable in all cases, and the
umen was identified. The analyzed arterial lengths encom-
assing the stented and reference segments ranged from 15
o 39.5 mm (23.2 5.2 mm). The pre- and post-PCI IVUS
olumetric measurements are summarized in Table 2. Both
EMV and LV were significantly higher at post-PCI IVUS
han at pre-PCI IVUS. Plaque volume was significantly
ower at post-PCI IVUS than at pre-PCI IVUS. The IVUS
esion morphologies at pre-PCI IVUS are summarized in
able 3. The angiographic characteristics of the subjects are
ummarized in Table 4. Inadequate reflow (CTFC40) on
he final angiograms after PCI was observed in 13 patients
21.7%).
The decrease in plaque volume (PV) was significantly
arger in patients with inadequate reflow than in those with
eflow (49.4 18.9 vs. 31.7 15.5 mm3, p 0.0010) (Fig.
). Three patients (5%) without mechanical vessel obstruc-
ion exhibited TIMI flow grade 1 after PCI. Fifty-seven
atients with TIMI flow grade 2 or 3 exhibited a mean
TFC of 25.9  16.7 after PCI. The post-PCI CTFC of
able 1. Clinical Characteristics and Clinical Results of Study
roup (n  60)
ge (yrs) 62  9.5
ales 54 (90%)
oronary risk factors
Systemic hypertension 26 (43%)
Diabetes mellitus 20 (33%)







re-infarction angina 37 (62%)
nset to recanalization time (min) 286  275
eak CK-MB (IU/l) 289  170
ata are presented as the mean value  SD or number (%) of patients.
CK-MB  creatine kinase-MB fraction.
Table 2. Intravascular Ultrasound Volumetric M
Reference Segments
Pre-PCI Po
EEMV (mm3) 379.7  125.1 434.0
LV (mm3) 129.3  51.2 219.1
PV (mm3) 250.4  80.2 214.9
Data are presented as the mean value  SD.
EEMV external elastic membrane volume; LV lumenvolume.hese 57 patients significantly correlated with PV (r 
.415, p 0.0012) (Fig. 2), but it did not show a significant
orrelation with either the onset-to-recanalization time or
he peak CK-MB (onset-to-recanalization time: r  0.060,
 0.66; CK-MB: r  0.221, p  0.10).
ISCUSSION
he principal finding of the present study was a significant
orrelation between PV during PCI and CTFC after PCI
n patients with AMI. Moreover, the PV was significantly
arger in patients with inadequate reflow than in those with
eflow. These findings suggest that PV hindered coronary
ow after the PCI procedure.
As the present study covered patients with AMI, the PV
as thought to contain both plaque and thrombus volume.
iven that IVUS is incapable of accurately assessing or
uantifying the thrombotic material (19), we defined PV in
his study as the sum of plaque and thrombus. Ahmed et al.
20) reported that the mechanisms of lumen enlargement
fter stenting involved significant axial redistribution of
laque from the lesion into the reference segments, vessel
xpansion, and either plaque embolization or compression.
he PV during PCI might be attributable to redistribu-
ion, compression, or embolization. The arterial segments
nalyzed in the present study encompassed reference seg-
ents 3.0 mm proximal and distal to the stented segments.
s the change in PV was far less pronounced in the
eference segments than in the stented segments (Fig. 3),
he redistribution out of the 3.0-mm reference segments was
ot believed to have an important effect on PV. Although
he compression could not be clearly identified, neither the
ompression nor redistribution was thought to have an
mpact on coronary flow after PCI. Thus, the present study
uggests that PV was mainly the result of PCI-induced
mbolization.
The relationship between PCI-induced embolization and
ngiographic no-reflow has been reported earlier. Angio-
urements in 60 Stented and
I Difference p Value (Paired)
32.8 54.4  30.9 0.0001
9.4 89.8  36.0 0.0001
4.7 35.5  17.8 0.0001
e; PCI percutaneous coronary intervention; PV plaque
able 3. Intravascular Ultrasound Morphologies in 60
ulprit Lesions
ositive remodeling 30 (50%)
ccentric 30 (50%)
issure/dissection 14 (23%)
ipid pool-like image 16 (27%)
uperficial calcium 25 (42%)
eep wall calcium 16 (27%)
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July 21, 2004:300–4 Plaque Volume Change and Coronary Flowraphic no-reflow is well known to occur after PCI in
egenerated saphenous vein grafts. In these cases, distal
mbolization of plaque or thrombus from the lesion site is
he likely mechanism (14). Prati et al. (21) found that a
arked reduction of the plaque–media area was associated
ith postprocedural CK-MB release in patients who un-
erwent coronary stenting for unstable angina, thereby
mplicating distal plaque embolization by stent deployment.
n a pre-PCI IVUS analysis of morphology at the culprit
esion in patients with AMI, Tanaka et al. (12) ascribed
ngiographic no-reflow to microvascular dysfunction result-
ng from the PCI-induced release of the lipid pool-like
laque contents. In a microscopic analysis of aspirate at the
ime of angiographic no-reflow, Kotani et al. (13) identified
atrogenic plaque disruption as one of the mechanisms for
ngiographic no-reflow during mechanical reperfusion ther-
py, and they witnessed an improvement in most of the
ngiographic no-reflow lesions when the intraluminal ath-
rosclerotic debris was removed by the thrombectomy cath-
ter. These reports suggest that PCI-induced embolization
as an important effect on coronary flow after PCI.
In experimental settings, however, no-reflow has been
ttributed to causes as diverse as oxygen free radical pro-
uction (22,23), cardiac sympathetic reflexes with resulting
lpha-adrenergic macrovascular and microvascular constric-
ion (24), local increases in angiotensin II receptor density





IMI flow grade 0 or 1 on initial angiogram 48 (80%)
ood collateral flow* on initial angiogram 8 (13%)
nadequate reflow (CTFC 40) 13 (21.7%)
IMI flow grade 0 or 1 after PCI 3 (5%)
Collateral flow was graded according to the Rentrop classification, with good
ollateral flow defined as grade 2 or 3. Data are presented as the number (%) of
atients.
CTFC  corrected TIMI frame count; LAD  left anterior descending; LCx 
eft circumflex; PCI  percutaneous coronary intervention; RCA  right coronary
rtery; TIMI  Thrombolysis In Myocardial Infarction.
igure 1. The difference in PV between patients with inadequate reflow
nd reflow. The PV was significantly larger in patients with inadequate
eflow than in those with reflow (49.4  18.9 vs. 31.7  15.5 mm3, p a.0010). PV  plaque volume.25,26), and interactions through selectins between acti-
ated polymorphonuclear leukocytes and the endothelium
27). Yet, the aforesaid findings have not been confirmed to
pply to angiographic no-reflow after PCI in patients with
MI. Strategies successful in preventing or treating exper-
mental models of no-reflow have not worked in human
rials. Other factors besides the ischemic myocardial damage
ight have hindered the coronary flow after PCI. Given
hat the peak CK-MB did not show a significant correlation
ith CTFC after the PCI procedure in the present study,
e conjectured that the myocardial damage was due not
nly to coronary flow, but also to other factors such as
reconditioning, collateral flow grade, ischemic duration,
nd area of myocardium at risk.
In addition to being significantly larger in patients with
nadequate reflow than in those with reflow, the PV in the
resent study correlated well with CTFC after PCI. This
attern suggests that the amount of PCI-induced embolization
s one of the important determinants of coronary flow in
atients with AMI.
igure 2. The relationship between PV during percutaneous coronary
ntervention (PCI) and corrected TIMI frame count (CTFC) after PCI. In
7 patients with TIMI flow grade 2 or 3, PV significantly correlated with
TFC after PCI (r  0.415, p  0.0012). PV  plaque volume.
igure 3. The changes of plaque volume obtained in the stented segments













































304 Sato et al. JACC Vol. 44, No. 2, 2004
Plaque Volume Change and Coronary Flow July 21, 2004:300–4The PV decreased in all 60 of the patients investigated in
he present study. Given the correlation between PV and
TFC after PCI, we propose that PCI-induced emboliza-
ion occurs and hinders coronary flow not only in patients
ith inadequate reflow, but also in those with reflow.
mplications. The coronary flow after reperfusion therapy
s reported to be a major determinant of clinical outcomes in
atients with AMI (3–11). As the PV during PCI has
egative impact on coronary flow after PCI, the prognosis
n patients with AMI may be influenced by the degree of
CI-induced embolization. Thus, distal protection devices
ight be useful for patients with AMI to reduce PCI-
nduced embolization and to achieve better coronary flow
fter PCI.
tudy limitations. The collapse of the culprit lesion due to
otal occlusions might have an effect on pre-PCI IVUS
easurements in patients with AMI. Glycoprotein IIb/IIIa
nhibitors were not used in the present study.
onclusions. The PV during PCI has a negative impact
n coronary flow after PCI in patients with AMI. Our data
uggest that PCI-induced embolization occurs and hinders
oronary flow not only in patients with inadequate reflow,
ut also in those with reflow.
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